About the Authors

Steven K. Hildemann

Affiliations University Clinic for Cardiology and Angiology I, University Heart Center, Freiburg-Bad Krozingen, Germany, Merck Research Laboratories/MSD Global Clinical Trial Operations, Haar, Germany

Jens Eberlein

Affiliation Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America

Bennett Davenport

Affiliations Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America, Integrated Department of Immunology, University of Colorado Denver and National Jewish Health, Denver, Colorado, United States of America, Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado, United States of America

Tom T. Nguyen

Affiliations Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America, Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado, United States of America

Francisco Victorino

Affiliations Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America, Integrated Department of Immunology, University of Colorado Denver and National Jewish Health, Denver, Colorado, United States of America

Dirk Homann

dirk.homann@ucdenver.edu

Affiliations Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America, Integrated Department of Immunology, University of Colorado Denver and National Jewish Health, Denver, Colorado, United States of America, Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado, United States of America

Competing Interests

The authors have the following interests. SKH leads the clinical research operations of MSD/Merck in Europe and is a full time employee of MSD/Merck. The current work is unrelated to any preclinical or clinical research ongoing at Merck and has received no financial or other support from MSD/Merck. Dirk Homann is a PLOS ONE Editorial Board member. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceived and designed the experiments: DH. Performed the experiments: JE BD TTN FV DH. Analyzed the data: JE BD DH. Wrote the paper: SKH DH.